Conversely, BMD patients were characterized by increased levels of the glycogen metabolic pathway being protein Phosphoglucomutase (PGM1), and l‐lactate dehydrogenase B chain (LDHB) increased compared with DMD (Figure3A). The gene discussed is DMD; the disease is Becker muscular dystrophy.